42 multiple-sequence-alignment positions at University of Manchester in United Kingdom
Sort by
Refine Your Search
-
-holder will provide leadership, management and strategic oversight of the bioinformatics service provision across the Faculty. They will drive alignment between the Faculty’s Technology Platforms, and
-
Director of AI Innovation and influencing strategy across the institution. Some of the things you might find yourself doing include: Developing and maintaining an AI innovation roadmap, aligned with
-
pathways induced in response to varied environmental exposures. Leveraging MRC centre expertise and support the PDRA will follow a holistic program of unbiased research, combining single-cell RNA-sequencing
-
, single cell RNA sequencing, complex co-culture systems and in vivo models to address our questions. We closely work with clinicians at The Christie Hospital in Manchester as well as groups both in the UK
-
, single cell RNA sequencing, complex co-culture systems and in vivo models to address our questions. We closely work with clinicians at The Christie Hospital in Manchester as well as groups both in the UK
-
The overall aim of this project is to develop a real-time monocular vision system for measuring bio test-tube heights in a rack and alignments in the space-defined labware carriage. The vision
-
mouse genetic manipulation to support the CoRE’s scientific aims. Projects will be prioritized where there is alignment between CoRE and DRP goals. The successful applicant will have a PhD and significant
-
transformation and growth, building and implementing the tools, frameworks and processes to facilitate the alignment of strategy, structure, skills, ways of working and culture to optimise the effectiveness
-
established behavioural tests. Post-mortem analysis will include immunohistochemistry and RNA sequencing to identify candidate treatments targeting menopause-sensitive vasodilation pathways. Full training will
-
spectroscopy) Conducting behavioural testing for cognitive function Post-mortem analysis (e.g. immunohistochemistry, RNA sequencing) to identify candidate treatments targeting menopause-sensitive vasodilation